FoundMyFitness #053 COVID-19 Q&A #1 with Rhonda Patrick, Ph.D.
Apr 14, 2020
Dr. Rhonda Patrick answers pressing COVID-19 questions, addressing how the virus affects children and its transmission. The discussion dives into potential treatments, including hydroxychloroquine and quercetin as zinc ionophores. Blood type's influence on susceptibility is explored, with intriguing insights on the protective nature of type O. Vitamin D's impact on health and COVID-19 risk is analyzed, alongside the potential benefits of sauna use and high-dose intravenous vitamin C. Melatonin's role in inflammation and virus severity is also examined.
AI Snips
Chapters
Transcript
Episode notes
COVID-19 in Children and Infants
- Children are less likely to develop severe COVID-19 than adults, potentially due to differences in ACE2 receptor maturity or immune response.
- Infants, especially those under one year old, are more vulnerable to severe infection than older children.
Hydroxychloroquine as a Potential Treatment
- Hydroxychloroquine, an antimalarial drug, is being investigated as a potential COVID-19 treatment, possibly by acting as a zinc ionophore.
- Early, small studies show mixed results, and larger trials are needed to confirm efficacy and safety.
Quercetin's Role
- Quercetin, a flavonoid found in various plants, has shown antiviral properties, including against SARS-CoV, in vitro.
- It may act as a zinc ionophore, potentially inhibiting viral replication.